Hailey Chastain
Physician Assistant · Florence, ALNPI 1184473894
Payments from drug & device makers
Across 210 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$439
- SK Life Science, Inc.$413
- UCB, Inc.$396
- Neurocrine Biosciences, Inc.$353
- Lilly USA, LLC$267
- Pfizer$238
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,014100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $439 |
| SK Life Science, Inc. | 18 | $413 |
| UCB, Inc. | 30 | $396 |
| Neurocrine Biosciences, Inc. | 13 | $353 |
| Lilly USA, LLC | 15 | $267 |
| Pfizer | 15 | $238 |
| AstraZeneca | 7 | $228 |
| Jazz Pharmaceuticals Inc. | 10 | $207 |
| Argenx US, Inc. | 6 | $193 |
| Johnson & Johnson | 5 | $156 |
| Biogen | 7 | $149 |
| Catalyst Pharmaceuticals, Inc. | 2 | $104 |
| EMD Serono, Inc. | 5 | $94 |
| Genentech USA, Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Acadia Pharmaceuticals Inc | 3 | $80 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Lundbeck LLC | 4 | $70 |
| MDD US Operations, LLC | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Merz Pharmaceuticals, LLC | 2 | $58 |
| Globus Medical | 2 | $57 |
| Novartis | 2 | $41 |
| Orthofix Medical, Inc. | 1 | $26 |
| Mirum Pharmaceuticals, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
How this compares
$4,014 in reported general payments places this provider in the 85th percentile of 846 physician assistant providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 38 | $918 |
| Memantine Hcl | 33 | $914 |
| Levetiracetam | 24 | $741 |
| Primidone | 21 | $365 |
| Topiramate | 20 | $254 |
| Ropinirole Hcl | 11 | $220 |
| Donepezil Hcl | 15 | $166 |
| Propranolol Hcl | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Florence
- Natalie GeorgeBirmingham$540K
- Lauren MillerAnniston$487K
- Valerie GoodwinBirmingham$33K
- Brianna BarryEnterprise$29K
- Ashley PeaceMobile$27K
- Andrea WombleHuntsville$22K
- Marlee BrunoDecatur$19K
- Mary TemplinBirmingham$19K
- Gregory SharpMobile$19K
- Elizabeth SimpsonMobile$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.